ATE425165T1 - Verfahren zur zubereitung von inhibitoren des nukleosid-metabolismus - Google Patents

Verfahren zur zubereitung von inhibitoren des nukleosid-metabolismus

Info

Publication number
ATE425165T1
ATE425165T1 AT00917509T AT00917509T ATE425165T1 AT E425165 T1 ATE425165 T1 AT E425165T1 AT 00917509 T AT00917509 T AT 00917509T AT 00917509 T AT00917509 T AT 00917509T AT E425165 T1 ATE425165 T1 AT E425165T1
Authority
AT
Austria
Prior art keywords
compound
preparing
pyrrolo
pyrimidin
amino
Prior art date
Application number
AT00917509T
Other languages
English (en)
Inventor
Richard Furneaux
Peter Tyler
Vern Schramm
Original Assignee
Ind Res Ltd
Einstein Coll Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Res Ltd, Einstein Coll Med filed Critical Ind Res Ltd
Application granted granted Critical
Publication of ATE425165T1 publication Critical patent/ATE425165T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT00917509T 1999-04-08 2000-04-07 Verfahren zur zubereitung von inhibitoren des nukleosid-metabolismus ATE425165T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ33509099 1999-04-08
NZ33616899 1999-06-08

Publications (1)

Publication Number Publication Date
ATE425165T1 true ATE425165T1 (de) 2009-03-15

Family

ID=26652045

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00917509T ATE425165T1 (de) 1999-04-08 2000-04-07 Verfahren zur zubereitung von inhibitoren des nukleosid-metabolismus

Country Status (17)

Country Link
US (4) US6693193B1 (de)
EP (2) EP1165564B1 (de)
JP (2) JP4430247B2 (de)
KR (1) KR100755110B1 (de)
CN (2) CN1196704C (de)
AT (1) ATE425165T1 (de)
AU (1) AU776540C (de)
CA (3) CA2368095C (de)
CY (2) CY1109103T1 (de)
DE (1) DE60041757D1 (de)
DK (2) DK2077268T5 (de)
ES (2) ES2324016T3 (de)
LT (1) LT2077268T (de)
NZ (1) NZ514660A (de)
PT (2) PT1165564E (de)
SI (2) SI2077268T1 (de)
WO (1) WO2000061783A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985848A (en) * 1997-10-14 1999-11-16 Albert Einstein College Of Medicine Of Yeshiva University Inhibitors of nucleoside metabolism
PT1165564E (pt) * 1999-04-08 2009-04-16 Einstein Coll Med Processo para a preparação de inibidores do metabolismo de nucleósidos
WO2002018371A1 (en) * 2000-08-29 2002-03-07 Industrial Research Limited Nucleoside metabolism inhibitors
US7098334B2 (en) * 2002-03-25 2006-08-29 Industrial Research Limited 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
US7553839B2 (en) 2002-08-21 2009-06-30 Industrial Research Limited 5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
NZ523970A (en) * 2003-02-04 2005-02-25 Ind Res Ltd Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases
US6972331B2 (en) 2003-04-23 2005-12-06 Biocryst Pharmaceuticals, Inc. Carboxy pyrrole, process of preparing and use as precursor
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
NZ533360A (en) * 2004-06-04 2007-02-23 Ind Res Ltd Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
NZ540160A (en) * 2005-05-20 2008-03-28 Einstein Coll Med Inhibitors of nucleoside phosphorylases
WO2007016291A2 (en) * 2005-07-27 2007-02-08 Albert Einstein College Of Medicine Of Yeshiva University Transition state structure of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases
NZ544187A (en) 2005-12-15 2008-07-31 Ind Res Ltd Deazapurine analogs of 1'-aza-l-nucleosides
WO2007097643A1 (en) * 2006-02-22 2007-08-30 Industrial Research Limited Analogues of coformycin and their use for treating protozoan parasite infections
WO2007097647A1 (en) * 2006-02-24 2007-08-30 Albert Einstein College Of Medicine Of Yeshiva University Methods of treating cancer
JP2009528996A (ja) * 2006-02-24 2009-08-13 インダストリアル リサーチ リミテッド ヌクレオシドホスホリラーゼ及びヌクレオシダーゼの阻害剤を用いて疾患を処置する方法
CN101094080B (zh) * 2006-06-22 2012-06-20 华为技术有限公司 一种即按即通系统中的计费方法
US8383636B2 (en) * 2006-09-07 2013-02-26 Industrial Research Limited Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase
ES2362805T3 (es) 2006-09-07 2011-07-13 Industrial Research Limited Inhibidores aminoacíclicos de nucleósido fosforilasas e hidrolasas.
DK2114925T3 (da) * 2006-12-22 2012-05-29 Ind Res Ltd Azetidin-analoger af nucleosidase- og phosphorylase-inhibitorer
WO2009132050A2 (en) 2008-04-21 2009-10-29 Otonomy, Inc. Auris formulations for treating otic diseases and conditions
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
US8784870B2 (en) 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
WO2010033236A2 (en) * 2008-09-22 2010-03-25 Albert Einstein College Of Medicine Of Yeshiva University Methods and compositions for treating bacterial infections by inhibiting quorum sensing
JP5861243B2 (ja) 2009-07-17 2016-02-16 アルバート アインシュタイン カレッジ オブ メディシン オブ イエシバ ユニバーシティ ５’−メチルチオアデノシンホスホリラーゼ及びヌクレオシダーゼの３−ヒドロキシピロリジン阻害剤
US9290501B2 (en) 2010-11-29 2016-03-22 Albert Einstein College Of Medicine, Inc. Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase
CN103391777A (zh) 2011-02-02 2013-11-13 普林斯顿大学理事会 作为病毒产生调节剂的去乙酰化酶调节剂
WO2013149258A2 (en) 2012-03-30 2013-10-03 Charles Drew University of Medicine and Science Compositions and methods for treating or preventing metabolic syndrome disorders
AR090699A1 (es) * 2012-04-18 2014-12-03 Biocryst Pharm Inc Compuestos inhibidores de la actividad de la arn polimerasa viral
EP3478269A4 (de) 2016-06-29 2020-04-08 Otonomy, Inc. Triclyceridformulierungen für das ohr und verwendungen davon
US11114184B2 (en) 2017-02-21 2021-09-07 Albert Einstein College Of Medicine DNA methyltransferase 1 transition state structure and uses thereof
CN110590786B (zh) * 2019-09-29 2021-12-03 上海大学 9-去氮鸟嘌呤合成工艺的改进方法
CN111704619B (zh) 2020-07-30 2021-10-19 四川大学 一种Forodesine的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE157607T1 (de) * 1992-11-06 1997-09-15 Ulrich Rindlisbacher Vorrichtung zum befestigen an einem gestell eines zweiradfahrzeugs
IL107616A0 (en) 1992-11-18 1994-02-27 Univ Johns Hopkins Formation of triple helix complexes of single stranded nucleic acids using nucleoside oligomers which comprise pyrimidine analogs
US6379911B2 (en) 1996-02-23 2002-04-30 Albert Einstein College Of Medicine Of Yeshiva University Enzyme detection/assay method and substrates
US5985848A (en) * 1997-10-14 1999-11-16 Albert Einstein College Of Medicine Of Yeshiva University Inhibitors of nucleoside metabolism
US6187777B1 (en) * 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
PT1165564E (pt) * 1999-04-08 2009-04-16 Einstein Coll Med Processo para a preparação de inibidores do metabolismo de nucleósidos
US6448799B1 (en) * 1999-09-30 2002-09-10 Hitachi Electronics Engineering Co., Ltd. Timing adjustment method and apparatus for semiconductor IC tester
WO2002018371A1 (en) 2000-08-29 2002-03-07 Industrial Research Limited Nucleoside metabolism inhibitors
US6458799B1 (en) 2000-08-31 2002-10-01 Biocryst Pharmaceuticals, Inc. Deazaguanine analog, preparation thereof and use thereof
US7098334B2 (en) 2002-03-25 2006-08-29 Industrial Research Limited 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
US7553839B2 (en) 2002-08-21 2009-06-30 Industrial Research Limited 5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
NZ523970A (en) 2003-02-04 2005-02-25 Ind Res Ltd Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases
NZ533360A (en) 2004-06-04 2007-02-23 Ind Res Ltd Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
WO2006014913A2 (en) 2004-07-27 2006-02-09 Biocryst Pharmaceuticals, Inc. Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase
NZ540160A (en) 2005-05-20 2008-03-28 Einstein Coll Med Inhibitors of nucleoside phosphorylases
NZ544187A (en) 2005-12-15 2008-07-31 Ind Res Ltd Deazapurine analogs of 1'-aza-l-nucleosides
JP2009528996A (ja) 2006-02-24 2009-08-13 インダストリアル リサーチ リミテッド ヌクレオシドホスホリラーゼ及びヌクレオシダーゼの阻害剤を用いて疾患を処置する方法
WO2007097647A1 (en) 2006-02-24 2007-08-30 Albert Einstein College Of Medicine Of Yeshiva University Methods of treating cancer

Also Published As

Publication number Publication date
US6693193B1 (en) 2004-02-17
SI1165564T1 (sl) 2009-08-31
AU776540B2 (en) 2004-09-16
LT2077268T (lt) 2017-08-10
HK1116472A1 (en) 2008-12-24
US7405297B2 (en) 2008-07-29
CN1370171A (zh) 2002-09-18
CY1109103T1 (el) 2014-07-02
EP1165564B1 (de) 2009-03-11
DK2077268T5 (en) 2017-08-28
US20060089498A1 (en) 2006-04-27
WO2000061783A2 (en) 2000-10-19
WO2000061783A3 (en) 2001-02-08
CA2368095C (en) 2009-10-06
US20070161667A1 (en) 2007-07-12
CN101062928A (zh) 2007-10-31
US20040181063A1 (en) 2004-09-16
CN101062928B (zh) 2010-10-06
CY1119099T1 (el) 2018-02-14
CA2634299A1 (en) 2000-10-19
US7022852B2 (en) 2006-04-04
JP2009173673A (ja) 2009-08-06
DK1165564T3 (da) 2009-06-08
KR20020018658A (ko) 2002-03-08
CN1196704C (zh) 2005-04-13
JP4430247B2 (ja) 2010-03-10
HK1088310A1 (en) 2006-11-03
US7211677B2 (en) 2007-05-01
ES2625636T3 (es) 2017-07-20
KR100755110B1 (ko) 2007-09-04
NZ514660A (en) 2004-03-26
EP1165564A2 (de) 2002-01-02
JP2002542170A (ja) 2002-12-10
CA2696826C (en) 2013-01-08
PT2077268T (pt) 2017-06-12
CA2696826A1 (en) 2000-10-19
SI2077268T1 (sl) 2017-07-31
PT1165564E (pt) 2009-04-16
EP1165564A4 (de) 2003-01-22
AU776540C (en) 2006-01-05
CA2368095A1 (en) 2000-10-19
CA2634299C (en) 2011-05-31
JP5070237B2 (ja) 2012-11-07
DE60041757D1 (de) 2009-04-23
DK2077268T3 (en) 2017-06-06
AU3846900A (en) 2000-11-14
ES2324016T3 (es) 2009-07-29
EP2077268A1 (de) 2009-07-08
EP2077268B1 (de) 2017-03-01

Similar Documents

Publication Publication Date Title
DE60041757D1 (de) Verfahren zur zubereitung von inhibitoren des nukleosid-metabolismus
ATE282020T1 (de) Verfahren zur herstellung von 2-aminomalonsäure- derivaten
PL342576A1 (en) Fungicidal 7-alkyltriazolopyrimidines
ATE117672T1 (de) Verfahren zur herstellung von nitrilen.
EP1690861A3 (de) Verfahren zur Herstellung von Duloxetin und Zwischenprodukte für dieses Verfahren
ES2159488A1 (es) Procedimiento para la preparacion de derivados de pirimidona con actividad antifugica.
PE20020524A1 (es) 7-oxo-piridopirimidinas como inhibidores de quinasas
DE69722111D1 (de) Verfahren zur reduktion von carbonylverbindungen
PL360499A1 (en) Method of manufacture of donepezyl
ATE201201T1 (de) Verfahren zur herstellung von pyrimidinderivaten
ATE295368T1 (de) Verfahren zur herstellung 3-amino-gallensaurer derivate
GB9610887D0 (en) Process
PT1230252E (pt) Derivados de beta-d-5-tioxilose processo de preparacao e utilizacao em terapeutica
ATE301723T1 (de) Verfahren zur herstellung von nukleosid- verbindung
DE69719450D1 (de) Verfahren zur Herstellung von Arylvinylsulfonen
GB9906328D0 (en) 2-Substituted RNA preparation
DE69819504D1 (de) Verfahren zur herstellung von 2-alkylthiobenzonitril-derivaten
DE59705130D1 (de) Verfahren zur Herstellung von 2-Alkoxy-6-(trifluormethyl)-pyrimidin-4-ol
PL326563A1 (en) Method of obtaining derivatives of methoxyiminophenyglyoxalic acid
DK159432C (da) Fremgangsmaade til fremstilling af 4-amino-5-dialkoxymethylpyrimidinderivater
ATE260883T1 (de) Verfahren zur herstellung von atropasäureethylester
PT1144436E (pt) Processo de preparacao de compostos biciclicos e aplicacao desse processo para a preparacao de um composto inibidor da ice
DE60306506D1 (de) Verfahren
MX9804766A (es) Procedimiento para hacer dihidropirimidinonas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1165564

Country of ref document: EP